| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1955) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A07EA03 |
| UNII: | VB0R961HZT |
| InChI Key | XOFYZVNMUHMLCC-ZPOLXVRWSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26O5 |
| Molecular Weight | 358.43 |
| AlogP | 1.77 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 91.67 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 26.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Glucocorticoid receptor agonist |
| Primary Target | |
|---|---|
| Glucocorticoid receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 1.38 | |
|
Enzyme
Transferase
|
- | - | - | - | 10.5 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | 3.74-5.68 | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 1
|
- | 1146 | 29 | 521 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 12.5-92.1 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | - | 23.3 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dermatomyositis | 4 | D003882 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Pemphigus | 4 | D010392 | ClinicalTrials |
| Erythema Multiforme | 4 | D004892 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Sarcoidosis, Pulmonary | 3 | D017565 | ClinicalTrials |
| Sciatica | 3 | D012585 | ClinicalTrials |
| Granulomatosis with Polyangiitis | 3 | D014890 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 3 | D029424 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Sinusitis | 3 | D012852 | ClinicalTrials |
| Nasal Polyps | 3 | D009298 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Urticaria | 3 | D014581 | ClinicalTrials |
| Deafness | 3 | D003638 | ClinicalTrials |
| Glomerulonephritis, IGA | 3 | D005922 | ClinicalTrials |
| Graft vs Host Disease | 3 | D006086 | ClinicalTrials |
| Uveitis | 3 | D014605 | ClinicalTrials |
| Rhinitis, Allergic, Perennial | 3 | D012221 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 3 | D020522 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | D015451 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Hodgkin Disease | 3 | D006689 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 3 | D015456 | ClinicalTrials |
| Lymphoma, T-Cell, Peripheral | 3 | D016411 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 3 | D015470 | ClinicalTrials |
| Cardiomyopathies | 3 | D009202 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Neuroblastoma | 3 | D009447 | ClinicalTrials |
| Sarcoma | 3 | D012509 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 3 | D054990 | ClinicalTrials |
| Kidney Diseases | 3 | D007674 | ClinicalTrials |
| Heart Diseases | 3 | D006331 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Renal Insufficiency, Chronic | 3 | D051436 | ClinicalTrials |
| Glomerulonephritis, Membranous | 3 | D015433 | ClinicalTrials |
| Leukemia, Lymphoid | 3 | D007945 | ClinicalTrials |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 | D056648 | ClinicalTrials |
| Lupus Nephritis | 3 | D008181 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Histiocytosis, Langerhans-Cell | 3 | D006646 | ClinicalTrials |
| Microscopic Polyangiitis | 3 | D055953 | ClinicalTrials |
| Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
| Hypereosinophilic Syndrome | 3 | D017681 | ClinicalTrials |
| Vasculitis | 3 | D014657 | ClinicalTrials |
| Polymyalgia Rheumatica | 3 | D011111 | ClinicalTrials |
| Uveitis, Intermediate | 3 | D015867 | ClinicalTrials |
| Central Nervous System Neoplasms | 3 | D016543 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Hodgkin Disease | 3 | D006689 | ClinicalTrials |
| Graft vs Host Disease | 3 | D006086 | ClinicalTrials |
| Purpura, Thrombotic Thrombocytopenic | 3 | D011697 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Leukemia-Lymphoma, Adult T-Cell | 3 | D015459 | ClinicalTrials |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054218 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 3 | D015456 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 3 | D008258 | ClinicalTrials |
| Retroperitoneal Fibrosis | 3 | D012185 | ClinicalTrials |
| Pemphigoid, Bullous | 3 | D010391 | ClinicalTrials |
| Sarcoma | 3 | D012509 | ClinicalTrials |
| Lymphoma, T-Cell, Peripheral | 3 | D016411 | ClinicalTrials |
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Cystic Fibrosis | 3 | D003550 | ClinicalTrials |
| Muscular Dystrophy, Duchenne | 3 | D020388 | ClinicalTrials |
| Tuberculosis | 3 | D014376 | ClinicalTrials |
| Pericarditis | 3 | D010493 | ClinicalTrials |
| Bronchiolitis Obliterans Syndrome | 3 | D000092122 | ClinicalTrials |
| Neoplasms, Plasma Cell | 3 | D054219 | ClinicalTrials |
| Lymphoma, B-Cell, Marginal Zone | 3 | D018442 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Kidney Failure, Chronic | 3 | D007676 | ClinicalTrials |
| Myeloproliferative Disorders | 2 | D009196 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Nephritis, Interstitial | 2 | D009395 | ClinicalTrials |
| Hearing Loss | 2 | D034381 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Burkitt Lymphoma | 2 | D002051 | ClinicalTrials |
| Immunoblastic Lymphadenopathy | 2 | D007119 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Chemical and Drug Induced Liver Injury | 2 | D056486 | ClinicalTrials |
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Glomerulosclerosis, Focal Segmental | 2 | D005923 | ClinicalTrials |
| Lymphohistiocytosis, Hemophagocytic | 2 | D051359 | ClinicalTrials |
| Castleman Disease | 2 | D005871 | ClinicalTrials |
| Lymphoma, T-Cell | 2 | D016399 | ClinicalTrials |
| Immunoglobulin G4-Related Disease | 2 | D000077733 | ClinicalTrials |
| Hepatitis, Alcoholic | 2 | D006519 | ClinicalTrials |
| Hearing Loss, Sensorineural | 2 | D006319 | ClinicalTrials |
| Myeloproliferative Disorders | 2 | D009196 | ClinicalTrials |
| Neuromyelitis Optica | 2 | D009471 | ClinicalTrials |
| Pneumonia, Viral | 2 | D011024 | ClinicalTrials |
| IgA Vasculitis | 2 | D011695 | ClinicalTrials |
| Vestibular Neuronitis | 2 | D020338 | ClinicalTrials |
| Churg-Strauss Syndrome | 2 | D015267 | ClinicalTrials |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | D020277 | ClinicalTrials |
| Blast Crisis | 2 | D001752 | ClinicalTrials |
| Thrombocythemia, Essential | 2 | D013920 | ClinicalTrials |
| Opsoclonus-Myoclonus Syndrome | 2 | D053578 | ClinicalTrials |
| Embolism, Cholesterol | 2 | D017700 | ClinicalTrials |
| Hepatitis, Autoimmune | 2 | D019693 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Geographic Atrophy | 2 | D057092 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Adrenal Insufficiency | 2 | D000309 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
| Hemangioma | 2 | D006391 | ClinicalTrials |
| Lung Diseases | 2 | D008171 | ClinicalTrials |
| Lymphoma, Large-Cell, Anaplastic | 2 | D017728 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Autoimmune Diseases | 2 | D001327 | ClinicalTrials |
| Hepatitis C | 2 | D006526 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Lymphoma, B-Cell | 2 | D016393 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Thymus Neoplasms | 2 | D013953 | ClinicalTrials |
| Polycythemia Vera | 2 | D011087 | ClinicalTrials |
| Hypersensitivity | 2 | D006967 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Hemophilia A | 2 | D006467 | ClinicalTrials |
| Premature Birth | 2 | D047928 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
| Lymphoma, AIDS-Related | 2 | D016483 | ClinicalTrials |
| Graves Ophthalmopathy | 2 | D049970 | ClinicalTrials |
| Lymphoproliferative Disorders | 2 | D008232 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome | 2 | D000163 | ClinicalTrials |
| Bell Palsy | 2 | D020330 | ClinicalTrials |
| AIDS-Associated Nephropathy | 2 | D016263 | ClinicalTrials |
| Stiff-Person Syndrome | 2 | D016750 | ClinicalTrials |
| Lichen Planus, Oral | 2 | D017676 | ClinicalTrials |
| Pulmonary Fibrosis | 2 | D011658 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 2 | D000744 | ClinicalTrials |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 2 | D000099067 | ClinicalTrials |
| Takayasu Arteritis | 2 | D013625 | ClinicalTrials |
| Lymphoma, Primary Effusion | 1 | D054685 | ClinicalTrials |
| Status Asthmaticus | 1 | D013224 | ClinicalTrials |
| Gangliosidoses | 1 | D005733 | ClinicalTrials |
| Esophageal Stenosis | 1 | D004940 | ClinicalTrials |
| Anemia, Diamond-Blackfan | 1 | D029503 | ClinicalTrials |
| Canavan Disease | 1 | D017825 | ClinicalTrials |
| Frontotemporal Dementia | 1 | D057180 | ClinicalTrials |
| Fanconi Anemia | 1 | D005199 | ClinicalTrials |
| Gaucher Disease | 1 | D005776 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Hematologic Diseases | 1 | D006402 | ClinicalTrials |
| Respiratory Syncytial Virus Infections | 1 | D018357 | ClinicalTrials |
| Glucose Intolerance | 1 | D018149 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 53-03-2 |
| ChEBI | 8382 |
| ChEMBL | CHEMBL635 |
| DrugBank | DB00635 |
| DrugCentral | 2253 |
| EPA CompTox | DTXSID4021185 |
| FDA SRS | VB0R961HZT |
| Human Metabolome Database | HMDB14773 |
| Guide to Pharmacology | 7096 |
| KEGG | C07370 |
| PharmGKB | PA451100 |
| PubChem | 5865 |
| SureChEMBL | SCHEMBL3288 |
| ZINC | ZINC000003875357 |